Common experiences during week 1-2 include slight changes in appetite patterns, mild nausea that differs from what tirzepatide caused (more constant and less meal-related), and subtle shifts in bowel habits
Examples: 16-year-old boy: BMI 27.5 (24.2 is 85th percentile) 16-year-old girl: BMI 29 (24.5 is 85th percentile) 17-year-old boy: BMI 28.4 (25.0 is 85th percentile) 17-year-old girl: BMI 29.5 (25.1 is 85th percentile) Exclusion or Contraindications GLP-1 therapy is not recommended for teens with: A personal or family history of medullary thyroid carcinoma or MEN2 A history of pancreatitis Severe gastrointestinal disease , such as gastroparesis or inflammatory bowel disease flare Current pregnancy or planning pregnancy Active eating disorder or untreated major psychiatric illness If your teen has any of these conditions, our providers will guide you toward safer, more appropriate options
Direct compounding models often allow dose changes with standard refill timelines and no penalty
Our experienced team creates individualized weightmanagement plans, combining advanced injectable therapy with comprehensive care to help you reach your unique wellness goals in a supportive clinical setting
For diabetes management, this means persistently elevated blood glucose readings or an A1c that hasn't decreased significantly